These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30603079)

  • 21. Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.
    Ba AK; Sanou I; Kristiansen PA; Sangaré L; Ouédraogo R; Ouattara K; Kienou M; Tiendrebeogo S; Tranchot J
    BMC Infect Dis; 2014 Oct; 14():546. PubMed ID: 25311771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis.
    Peterson ME; Li Y; Shanks H; Mile R; Nair H; Kyaw MH;
    BMJ Open; 2019 Apr; 9(4):e024343. PubMed ID: 31005910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing and dynamic epidemiology of meningococcal disease.
    Halperin SA; Bettinger JA; Greenwood B; Harrison LH; Jelfs J; Ladhani SN; McIntyre P; Ramsay ME; Sáfadi MA
    Vaccine; 2012 May; 30 Suppl 2():B26-36. PubMed ID: 22178525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological burden of meningococcal disease in Latin America: A systematic literature review.
    Vespa Presa J; Abalos MG; Sini de Almeida R; Cane A
    Int J Infect Dis; 2019 Aug; 85():37-48. PubMed ID: 31085314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017.
    Nuttens C; Findlow J; Balmer P; Swerdlow DL; Tin Tin Htar M
    Euro Surveill; 2022 Jan; 27(3):. PubMed ID: 35057902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines.
    Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L
    Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe.
    Bai X; Borrow R; Bukovski S; Caugant DA; Culic D; Delic S; Dinleyici EC; Eloshvili M; Erdősi T; Galajeva J; Křížová P; Lucidarme J; Mironov K; Nurmatov Z; Pana M; Rahimov E; Savrasova L; Skoczyńska A; Smith V; Taha MK; Titov L; Vázquez J; Yeraliyeva L
    J Infect; 2019 Dec; 79(6):528-541. PubMed ID: 31682877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningococcal vaccine evolution.
    Bona G; Guidi C
    J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of vaccination on meningococcal epidemiology.
    Stefanelli P; Rezza G
    Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
    Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
    BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape.
    Sáfadi MA; González-Ayala S; Jäkel A; Wieffer H; Moreno C; Vyse A
    Epidemiol Infect; 2013 Mar; 141(3):447-58. PubMed ID: 22877581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations for controlling invasive meningococcal disease in high income countries.
    Holst J; Nøkleby H; Bettinger JA
    Vaccine; 2012 May; 30 Suppl 2():B57-62. PubMed ID: 22607900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
    Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
    BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
    Tzanakaki G; Cabrnochová H; Delić S; Draganescu A; Hilfanova A; Onozó B; Pokorn M; Skoczyńska A; Tešović G
    Hum Vaccin Immunother; 2024 Dec; 20(1):2301186. PubMed ID: 38173392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010.
    Ibarz-Pavón AB; Lemos AP; Gorla MC; Regueira M; ; Gabastou JM
    PLoS One; 2012; 7(8):e44102. PubMed ID: 22952888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.
    Chen WH; Neuzil KM; Boyce CR; Pasetti MF; Reymann MK; Martellet L; Hosken N; LaForce FM; Dhere RM; Pisal SS; Chaudhari A; Kulkarni PS; Borrow R; Findlow H; Brown V; McDonough ML; Dally L; Alderson MR
    Lancet Infect Dis; 2018 Oct; 18(10):1088-1096. PubMed ID: 30120069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.
    Chiou CS; Liao JC; Liao TL; Li CC; Chou CY; Chang HL; Yao SM; Lee YS
    BMC Infect Dis; 2006 Feb; 6():25. PubMed ID: 16478548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.
    Sáfadi MA; McIntosh ED
    Expert Rev Vaccines; 2011 Dec; 10(12):1717-30. PubMed ID: 22085175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serogroup A meningococcal conjugate vaccines in Africa.
    Kristiansen PA; Jørgensen HJ; Caugant DA
    Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.